• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Editas Medicine released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 15.78 M and EPS of USD -1.8255
04:00
Editas Medicine released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 7.543 M (forecast USD 4.945 M), actual EPS USD -0.2787 (forecast USD -0.3121)
04:00
Oct6
Editas Medicine to Report CRISPR Gene Editing Drug Data at ESGCT Conference
13:00
Aug13
Editas Medicine released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 8.236 M, actual EPS USD -1.5443
03:00
Editas Medicine released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 3.578 M (forecast USD 1.805 M), actual EPS USD -0.6306 (forecast USD -0.3836)
03:00
Jul3
Editas Medicine Showcases Progress in Gene Editing for Beta Thalassemia and Sickle Cell Disease
13:20

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.543 M, Net Income -25.12 M, EPS -0.2787

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.578 M, Net Income -53.24 M, EPS -0.6306

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 4.658 M, Net Income -76.09 M, EPS -0.9161

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
19.880
+390.86%
+16.030
ASPC
24.150
+130.44%
+13.670
SRV.RT
0.0950
+123.53%
+0.052
ENVB
9.710
+64.02%
+3.790
BEAT
1.280
+58.91%
+0.475
BDRX
6.398
+57.21%
+2.230
MIGI
7.000
+52.17%
+2.370
CGTL
0.9547
+44.67%
+0.330
GRAN
3.469
+44.53%
+1.069
PLAB
37.010
+44.06%
+11.310
View More